PharmaTelevision Appoints Managing Director

OXFORD, England, March 29, 2010 – PharmaVentures, the global corporate advisory serving the biotechnology
and pharmaceutical industry, is pleased to announce the appointment of Anne
Vindenes Allen as Managing Director of its new subsidiary, PharmaTelevision
Ltd.

PharmaTelevision is the leading television company dedicated to assisting
biopharma companies in their business information and communication needs. In
addition [...]

CSL Limited Publishes First Corporate Responsibility Report

MELBOURNE, Australia, March 29, 2010 – CSL Limited (ASX: CSL), Australia's leading biopharmaceutical company,
has released its first Corporate Responsibility Report, combining information
about the Company's economic, social and environmental performance for 2009.

"CSL has experienced significant growth over the past 10 years, which has
been underpinned by our commitment to conducting our business [...]

Health Robotics Launches i.v.SOFT Global Beta Installation Program at the European Association of Hospital Pharmacists

BOZEN, Sud-Tirol, Italy, March 29, 2010 – Health Robotics today announced the successful global launch of the Beta
Installation kick-off for its 3 latest i.v.SOFT Workflow Engine software
automation modules [Assist, Label+ and Profile] in Nice [France], the 2010
venue for the European Association of Hospital Pharmacists. i.v.SOFT helps
Pharmacy Technicians, I.V. Room Supervisors, and Pharmacy Directors to
compound [...]

Hoya Corporation Appoints Chris Japp Global President of Hoya (Pentax) Lifecare Division

TOKYO, March 29, 2010 – Hoya Corporation announced the appointment of Chris N. Japp to the
position of Global President, Hoya (Pentax) Lifecare Division.

"Hoya Corporation is extremely pleased to have Chris Japp lead the global
division for Lifecare," said Hiroshi Hamada, COO of Hoya Corporation. "Chris
brings a wealth of knowledge, insight and [...]

Sanofi-aventis: Multaq(R) Receives Positive Recommendation by NICE in New Appraisal Consultation Document

PARIS, March 30, 2010 – Sanofi-aventis (EURONEXT: SAN, and NYSE: SNY) announced today
that the National Institute for Health and Clinical Excellence (NICE) in
England and Wales, has just published a new appraisal consultation document
(ACD)[1] for Multaq(R) (dronedarone) indicating its intention to recommend
Multaq(R) use for the management of patients with atrial fibrillation (AF).

[...]

New Intervention Priority Score in Elsevier’s MTM 360 to Enhance Medicare Medication Therapy Management Efforts

ORLANDO, Florida, March 30, 2010 – Elsevier Clinical Decision Support, a leading provider of
medical information and solutions, announced today that it has developed a
quantitative ranking system that enables health plans to better control their
medication therapy management (MTM) programs for Medicare Part D members.

The Intervention Priority Score (IPS) is a new [...]

New Drug Application for Voclosporin Accepted for Priority Review by FDA

EDMONTON, Canada, March 30, 2010 – Isotechnika Pharma Inc. (TSX: ISA) today announced that the New Drug
Application (NDA) for the Company's next generation calcineurin inhibitor,
voclosporin, has been accepted for priority review as filed by the U.S.
Food and Drug Administration (FDA). The application was submitted by
Isotechnika's partner, Lux Biosciences, Inc.

The [...]

Safelayer Consolidates its Strategic Alliance With Indra for Citizen e-ID/e-Passport Solutions

Both Companies Foresee an Increase in Demand for the new Generations of Citizen Identification Solutions for the Coming Years

BARCELONA, March 30, 2010 – Safelayer Secure Communications (www.safelayer.com) -
leader in the security and trust market for information and communication
technologies – consolidates its strategic alliance with the multinational
Indra for its international expansion. The companies are currently [...]

Hospira Completes Acquisition of Orchid’s Generic Injectable Pharmaceuticals Business

LAKE FOREST, Illinois, March 30, 2010 – — Gains New Manufacturing Capabilities and Expands Global Reach –

Hospira, Inc. (NYSE: HSP), the world leader in generic injectable
pharmaceuticals, today announced it has completed the acquisition of the
generic injectable pharmaceuticals business of Orchid Chemicals &
Pharmaceuticals Ltd. (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian
pharmaceuticals [...]

Informex Specialty Chemical Conference Announces Keynote & Speakers

PRINCETON, New Jersey, March 30, 2010 – Informex Show Management today announced the keynote speaker for the
inaugural Informex Specialty Chemicals Conference, to be held in Houston,
Texas on May 11th, will be Lee E. Mikles*, President and CEO of FutureFuel
Corp., the leading US manufacturer of biofuels and specialty chemicals.
Launched in response to industry feedback and [...]

IndiaMART.com Sponsors India Packaging Show 2010

NEW DELHI, March 31, 2010 -

– 75 percent of total demand for packaging and associated equipment comes
from food processing industry and pharmaceutical industry.

– There are around 600-700 packaging machinery manufacturers out of which
95 percent [...]

Elsevier Adds FDA Advisory Committee Content to PharmaPendium(TM)

Offers Preclinical, Clinical Drug Development and Regulatory Affairs More Access to Comparative Data

NEW YORK, March 31, 2010 – PharmaPendium (www.info.pharmapendium.com/), Elsevier
announces a new release that adds extensive FDA Advisory Committee content to
the online resource for authoritative preclinical, clinical and post-market
drug information. These documents provide preclinical and clinical drug
development and regulatory affairs departments with a [...]

Essilor Supports the Planned Friendly Bid for Sperian Protection

CHARENTON-LE-PONT, France, March 31, 2010 – Essilor International announced today that it has signed an
agreement with the Cinven Investment Fund and Mrs. Ginette Dalloz concerning
Essilor's 15.05% stake (23.21% voting rights) in Sperian Protection.
According to the terms of the deal and subject to certain conditions, Cinven
will launch a cash tender offer for Sperian Protection through [...]

Medefield Adds Key Executives to Lead Lyon and Hamburg Offices

LONDON, March 31, 2010 – Medefield, the leading global physician and related HCP fieldwork
services provider, announces two senior appointments to lead its global
expansion, establishing offices in Lyon and Hamburg.

Anne-Beatrice Clidassou is appointed Managing Director of our office in
Lyon, France. Anne-Beatrice has over 12 years of experience in healthcare
market research. She [...]

Chiltern Announces Investment in Endpoint

LONDON, March 31, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO) announced a strategic partnership with endpoint. With this
investment, Chiltern becomes a minority shareholder in the company
established in April 2009.

Glenn Kerkhof, Chiltern CEO, stated, "Chiltern's decision to invest in
endpoint is representative of our commitment to seek collaborations [...]

Teva UK Limited Launches Temozolomide Capsules

CASTLEFORD, England, March 31, 2010 – We are pleased to announce the launch of temozolomide available in 5mg,
20mg, 100mg, 140mg, 180mg and 250mg strength capsules. Temozolomide is
indicated for the oncological treatment of brain tumours, specifically(1):

– adult patients with newly-diagnosed glioblastoma multiforme
concomitantly with radiotherapy (RT) [...]

Cellvax Expands its Preclinical Service Offers by Moving to a New Laboratory Facility With an Access to Large Animals and a Number of New Technical Plat-Forms

PARIS, March 31, 2010 – Cellvax is a French service company which provides complete in
vitro & in vivo preclinical innovating services allowing to accelerate the
drug development process for unmet needs related with severe human diseases,
mainly in oncology field.

Cellvax was created in 2001 as a French SME by a motivated and
complementary [...]

Clearstone Expands Testing Capabilities at Laboratory in Toronto

TORONTO, March 31, 2010 – Clearstone Central Laboratories, a leading global provider of clinical
laboratory and centralized cardiac services for clinical trials, today
announced the expansion of testing capabilities at its Toronto laboratory.
Additional safety as well as esoteric testing capacity and capabilities will
be added to the existing operations.

"Since the acquisition of this [...]

Debt Ridden Britain Relies on Credit for Dental Bills

ANDOVER, England, March 31, 2010 – In the last year, 39% of Britons have had to pay for dental
bills over GBP50 using a credit card, and 2% have been forced to take out a
loan. These shocking results come as even more people struggle to find an NHS
dentist for themselves and their children (up from [...]

Recent Survey Reveals Decay in Nation’s Dental Health

ANDOVER, England, April 1, 2010 – A lack of affordable dental care could have a severe effect on
the future state of Britain's teeth, according to a recent survey into the
oral health of the nation carried out by healthcare provider Simplyhealth.

Just half of the population is currently under the care of [...]

Survey Reveals the Value of Dental Benefits

ANDOVER, England, April 1, 2010 – Simplyhealth's Annual Dental Survey 2010 has highlighted the
value that HR managers now place on dental benefits. Two thirds of companies
believe dental benefits reduce sickness absence, a number that has more than
doubled since 2008 (30%). A further two thirds believe they improve morale
and aid recruitment and retention. As dental [...]

AmVac AG Granted Patent for new Vaccine Development

ZUG, Switzerland, April 1, 2010 – The Swiss company AmVac AG, a biopharmaceutical company
located in Zug, has been granted a European patent (EP 1851 239 B1) for its
Sendai platform technology for its subsidiary company AmVac Research GmbH.
Thus, the novel technology for producing vaccines that has been developed at
the research site in Martinsried near Munich, [...]